Activation of monocytes and cytokine production in patients with peripheral atherosclerosis obliterans

Journal of Inflammation

Volumn 8, Issue , 2011, Pages

  Corrêa, Camila R ^a   Dias Melicio, Luciane A ^a   Calvi, Sueli A ^a   Lastária, Sidney ^a   Soares, Angela M V C ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

cytokines; monocytes; Peripheral arteriosclerosis obliterans; peripheral blood

Indexed keywords

GAMMA INTERFERON; HYDROGEN PEROXIDE; INTERLEUKIN 10; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CANDIDA ALBICANS; CELL ACTIVATION; CELL FUNCTION; CELL ISOLATION; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNGICIDAL ACTIVITY; HUMAN; HUMAN CELL CULTURE; IN VITRO STUDY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN BLOOD LEVEL;

CANDIDA ALBICANS;

EID: 80052103627     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-8-23     Document Type: Article

References (27)

1. Peripheral arterial disease. Gornik HL, Beckman JA, Circulation 2005 111 169 e172 10.1161/01.CIR.0000160581.58633.8B 15811861
2. Ox-LDL induces monocyte-to-macrophage differentiation in vivo: Possible role for the macrophage colony stimulanting factor receptor (M-CSF-R). Fuhrman B, Partoush A, Volkova N, et al. Atherosclerosis 2008 196 598 607 10.1016/j.atherosclerosis.2007.06.026 17675037
3. Oxidized LDL: Diversity, patters of recognition, and pathophisiology. Levitan I, Volkov S, Subbaiah PV, Antioxid Redox Signal 2010 13 39 75 10.1089/ars.2009.2733 19888833
4. Interleukin-10 attenuates the response to vascular injury. Zimmerman MA, Reznikov LL, Raeburn CD, et al. J Surg Res 2004 121 206 213 10.1016/j.jss.2004. 03.025 15501460 (Pubitemid 39387461)
5. T Lymphocytes from human atherosclerosis plaques recognize oxidized low-density lipoprotein. Stemme S, Faber B, Holm J, et al. Proc Natl Acad Sci USA 1995 92 3893 3897 10.1073/pnas.92.9.3893 7732003
6. Interferon and health disease. Angerio AD, Crit Care Nurs 2009 32 159 162
7. Interleukin-6 gene transcripts are expressed in atherosclerotic lesions of genetically hiperlipidemic rabbits. Ikeda U, Ikeda M, Seino Y, et al. Atherosclerosis 1992 92 213 213 10.1016/0021-9150(92)90280-T 1632849
8. Reciprocal induction of IL-10 and IL-12 from macrophages by low-density lipoprotein and its oxidized forms. Varadhachary AS, Monestier M, Salgame P, Cellular Immunology 2001 213 45 45 10.1006/cimm.2001.1855 11747355 (Pubitemid 34074969)
9. A simple colorimetric method for the measurement of hydrogen peroxidase by cells in culture. Pick E, Keisari Y, J Immunol Methods 1980 36 161 161
10. Rapid microassay for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using in automatic enzyme immunoassay reader. Pick E, Mizel D, J Immunol Methods 1981 46 211 226 10.1016/0022-1759(81) 90138-1 6273471 (Pubitemid 11020859)
11. Bioestatistical analysis. Zar JH, Englandood cliffs. Prentice hall 1998
12. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. Ridker PM, Hennekens CH, Buring JE, et al. The New England Journal of Medicine 2000 342 836 843 10.1056/NEJM200003233421202 10733371 (Pubitemid 30165206)
13. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standart cholesterol screening as predictors of peripheral arterial disease. Ridker PM, Stampfer MJ, Rifai N, J Am Med Assoc 2001 285 2481 2585 10.1001/jama.285.19.2481
14. Lipoprotein disorders and cardiovascular risk. Genest J, J Inherit Metab Dis 2003 26 267 287 10.1023/A:1024449603891 12889666 (Pubitemid 36889747)
15. Alpha-1- acid glicoprotein: an acute phase protein with inflammatory and immunomodulating properties. Hochepied T, Berger FG, Baumann H, et al. Cytokine Growth factor Rev 2003 14 25 32 10.1016/S1359-6101(02)00054-0 12485617 (Pubitemid 36098429)
16. HDL counterbalances the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kB activation in smooth muscle cells. Robbesyn F, Garcia V, Auge N, et al. The FASEB Journal 2003 17 743 745 12586748
17. Atherosclerosis: cell biology and lipoproteins. Ares MPS, Current Opinion Lipidology 2004 15 231 234 10.1097/00041433-200404000-00019 (Pubitemid 38453412)
18. An update on the role of markers of inflammation in atherosclerosis. Corrado E, Rizzo M, Coppola G, et al. J Atherosclerosis and Thrombosis 2010 17 1 11 10.5551/jat.2600
19. Cytokine signatures in atherosclerotic claudicants. De Palma RG, Hayes VW, Cafferata HT, et al. J Surg Res 2003 111 215 221 10.1016/S0022-4804(03) 00075-1 12850465 (Pubitemid 36808912)
20. Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy. Tentolouris C, Tousoulis D, Antoniades C, et al. Int J cardiol 2004 94 301 305 10.1016/j.ijcard.2003.08.002 15093997 (Pubitemid 38490677)
21. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral artherial disease. Fiotti N, Giansante C, Ponte E, et al. Atherosclerosis 1999 145 51 60 10.1016/S0021-9150(99)00013-1 10428295 (Pubitemid 29292700)
22. Increased Th1 activity in patients with coronary artery disease. Fernades JL, Manomi RL, Orford JL, et al. Cytokine 2004 26 131 137 10.1016/j.cyto.2004. 01.007 15135807 (Pubitemid 38596923)
23. Interleukin-10 attenuates the response to vascular injury. Zimmerman MA, Reznikov LL, Raeburn CD, et al. J Surg Res 2004 121 206 213 10.1016/j.jss.2004. 03.025 15501460 (Pubitemid 39387461)
24. Inflammatory and non-invasive vascular markers: The multimarker approach for risk stratification in coronary artery disease. Ikonomidis I, Stamatelopoulos K, Lekakis J, et al. Atherosclerosis 2008 199 3 11 10.1016/j.atherosclerosis.2008.02.019 18378239
25. Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Molavi B, Mehta JL, Current Opinion in Cardiology 2004 19 488 493 10.1097/01.hco. 0000133657.77024.bd 15316458 (Pubitemid 39222966)
26. Oxidized low density lipoprotein suppresses expression of inducible cycloxigenase in macrophage. Eligini S, Colli S, Basso F, et al. Arterioscler Thromb Vasc Biol 1999 19 1719 1725 10.1161/01.ATV.19.7.1719 10397690 (Pubitemid 29323831)
27. Supression of macrophage eicosanoid synthesis by atherogenic lipoproteins is profoundly affected by cholesterol-fatty acyl esterification and the niemann-pick c pathway of lipid trafficking. Leventhal AR, Leslie CC, Tabas I, The Journal of Biological Chemistry 2004 279 8084 8092 14638686 (Pubitemid 38294698)